← back to search
David S. Garlick
University of Massachusetts Chan Medical School
· US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cell biology, Tramp, Integrin, In vivo, Downregulation and upregulation, and Terminal (telecommunication).
h-index
—
citations
96
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation
eLife
2018
cited by
46
position: middle
doi
β<sub>1</sub> integrins mediate resistance to ionizing radiation in vivo by inhibiting c‐Jun amino terminal kinase 1
Journal of Cellular Physiology
2013
cited by
50
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Roger J. Davis
· University of Massachusetts Chan Medical School
2
papers (2013–2018)
Thomas J. FitzGerald
· Memorial Medical Center
1
papers (2013–2013)
Yvonne J. K. Edwards
· University of Alabama at Birmingham
1
papers (2018–2018)
Matthew J. Zarif
· University of Massachusetts Chan Medical School
1
papers (2013–2013)
Irwin Leav
· University of Massachusetts Chan Medical School
1
papers (2013–2013)
Adam P. Dicker
· Thomas Jefferson University
1
papers (2013–2013)
Andrea Morrione
· Thomas Jefferson University
1
papers (2013–2013)
Hira Lal Goel
· University of Massachusetts Chan Medical School
1
papers (2013–2013)
Lucia R. Languino
· Thomas Jefferson University
1
papers (2013–2013)
Dario C. Altieri
· Thomas Jefferson University
1
papers (2013–2013)
Nomeda Girnius
· Harvard University
1
papers (2018–2018)
Qin Liu
· Hegang People's Hospital
1
papers (2013–2013)
Chung-Cheng Hsieh
· Harvard University
1
papers (2013–2013)
Aejaz Sayeed
· Roswell Park Comprehensive Cancer Center
1
papers (2013–2013)
Michael Breen
· University of Massachusetts Chan Medical School
1
papers (2013–2013)